Susquehanna International Group, LLP Harmony Biosciences Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 26,306 shares of HRMY stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,306
Previous 26,800
1.84%
Holding current value
$1.03 Million
Previous $899,000
11.79%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HRMY
# of Institutions
228Shares Held
45.4MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$440 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$229 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$138 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$102 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$98.5 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.32B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...